Portal de Periódicos da CAPES

The β‐agonist controversy: fact or fiction?

1992; Wiley; Volume: 22; Issue: 7 Linguagem: Inglês

10.1111/j.1365-2222.1992.tb00187.x

1365-2222

Brian J. Lipworth,

Pharmacological Effects and Assays

Clinical & Experimental AllergyVolume 22, Issue 7 p. 659-664 Free Access The β-agonist controversy: fact or fiction? B. J. Lipworth, B. J. Lipworth Department of Clinical Pharmacology, Ninewells Hospital and Medical School, Dundee, Scotland DD1 9SY, U.K.Search for more papers by this author B. J. Lipworth, B. J. Lipworth Department of Clinical Pharmacology, Ninewells Hospital and Medical School, Dundee, Scotland DD1 9SY, U.K.Search for more papers by this author First published: July 1992 https://doi.org/10.1111/j.1365-2222.1992.tb00187.xCitations: 2AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat References 1 Crane J, Pearce N, Flatt A et al. Prescribed fenoterol and death from asthma in New Zealand, 1981–1983: case-control study. Lancet 1989; 1: 917– 22. 2 Pearce N, Grainger J, Atkinson M et al. Case control study of prescribed fenoterol and death from asthma in New Zealand 1977–1981. Thorax 1990; 45: 170– 5. 3 Grainger J, Woodman K, Pearce N, Crane J, Burgess C, Keane A, Beasley R. Prescribed fenoterol and death from asthma in New Zealand, 1981–7: a further case-control study. Thorax 1991; 46: 105– 11. 4 Crane J, Burgess C, Beasley R. Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline. Thorax 1989b; 44: 136– 40. 5 Wong CS, Pavord ID, Williams J, Britton JR, Tattersfield AE. Bronchodilator, cardiovascular, and hypokalaemic effects of enoterol, salbutamol and terbutaline in asthma. Lancet 1990; 336: 1396– 9. 6 Sears MR, Taylor RD, Print CG et al. Regular inhaled β-agonist treatment in bronchial asthma. Lancet 1990; 336: 1391– 6. 7 Lands AM, Arnold A, McAuliff JP, Ludvena FP, Brown PE Jr. Differentiation of receptor systems activated by sympathomimetic amines. Nature 1967; 214: 597– 8. 8 Wagner J, Reinhardt D, Schumann HJ. Comparison of the bronchodilator and cardiovascular actions of isoprenaline, Th 1165a, terbutaline and salbutamol in cats and isolated organ preparations. Res Exper Med 1973; 162: 49– 62. 9 O'Donnell SR, Wanstall JC. Evidence that the efficacy (intrinsic activity) of fenoterol is higher than that of salbutamol on β-adrenoceptors in guinea-pig trachea. Eur J Pharmacol 1978; 47: 333– 40. 10 O'Donnell SR. An examination of some β-adrenoceptor stimulants for selectivity using the isolated trachea and atria of the guinea pig. Eur J Pharmacol 1972; 19: 371– 9. 11 Brodde OE, Karad K, Zerkowski HR, Rohm N, Reidmesiter JC. Coexistence of beta-1 and beta-2 adrenoceptors in human right atrium. Direct identification by (-)-[125I]-iodocyanopindolol binding. Circ Res 1983; 53: 752– 8. 12 Heitz A, Schwartz J, Volly J. Beta-adrenoceptors of the human myocardium: determination of beta-1 and beta-2 subtypes by radioligand binding. Br J Pharmacol 1983; 80: 711– 17. 13 Ask JA, Stene-Larsen G, Helle KKB, Reech F. Functional β1 and β2-adrenoreceptors in the human myocardium. Acta Physiol Scand 1985; 123: 81– 8. 14 Brodde OE, O'Hara N, Zerkouskitte, Rohn N. Human cardiac β-adrenoceptor: both β1 and β2-adrenoceptors are functionally coupled to adenylate cyclase in the right atrium. J Cardiovasc Pharmacol 1984; 6: 1184– 91. 15 Wilson C, Lincoln C. β-Adrenoceptor subtypes in human, rat, guinea-pig, and rabbit atria. J Cardiovasc Pharmacol 1984; 6: 1216– 21. 16 Mugge A, Posselt D, Reiner U, Schmitz W, Scholz H. Effects of the β2-adrenoceptor agonists fenoterol and salbutamol on force of contraction in isolated human ventricular myocardium. Klin Wochenschr 1985; 63: 26– 31. 17 Windom H, Burgess CD, Siebens RWL et al. The pulmonary and extrapulmonary effects of inhaled β-agonists in patients with asthma. Clin Pharmacol Ther 1990; 48: 296– 301. 18 Hall JA, Petch MC, Brown MJ. Intracoronary injections of salbutamol demonstrate the presence of functional beta-2 adrenoceptors in the human heart. Circ Res 1989; 65: 546– 53. 19 Lipworth BJ, McDevitt DG. Beta-adrenoceptor responses to inhaled salbutamol in normal subjects. Eur J Clin Pharmacol 1989; 36: 239– 45. 20 Lipworth BJ, Brown RA, McDevitt DG. Assessment of airways, tremor and chronotropic responses to inhaled salbutamol in the quantification of beta-2 adrenoceptor blockade. Br J Clin Pharmac 1989; 23: 95– 102. 21 Strauss MH, Reeves RA, Smith DL, Leenen FHH. The role of cardiac beta-1 receptors in the haemodynamic response to a beta-2 agonist. Clin Pharmacol Ther 1986; 40: 108– 15. 22 Lipworth BJ, Irvine NA, McDevitt DG. A dose-ranging study to evaluate the β1-adrenoceptor selectivity of bisoprolol. Eur J Clin Pharmacol 1991; 40: 135– 9. 23 Newnham DM, Wheeldon NM, McDevitt DG, Lipworth BJ. Comparison of the β2-adrenoceptor selectivity of inhaled fenoterol and salbutamol. Proceedings of the American Thoracic Society. Am Rev Respir Dis 1992, abstract in press. 24 Jeppsson AB, Lofdahl CG, Waldeck B, Widmark E. On the predictive value of experiments in vitro in the evaluation of the effect duration of bronchodilator drugs for local administration. Pulm Pharmacol 1989; 2: 81– 5. 25 Kung M, Croley SW, Phillips BA. Systemic cardiovascular and metabolic effects associated with the inhalation of an increased dose of albuterol; influence of mouth rinsing and gargling. Chest 1987; 91: 382– 7. 26 Lipworth BJ, McDevitt DG, Struthers AD. Systemic beta-adrenoceptor responses to salbutamol given by metered-dose inhaler alone and with pear-shaped spacer attachment: comparison of electrocardiographic, hypokalaemic and haemodynamic effects. Br J Clin Pharmac 1989; 27: 837– 42. 27 Lipworth BJ, Clark RA, Dhillon DP, McDevitt DG. Subsensitivity of β-adrenoceptor responses in asthmatic patients taking regular low-dose inhaled salbutamol. Eur J Clin Pharmacol 1990; 38: 203– 5. 28 Lipworth BJ, Struthers AD, McDevitt DG. Tachyphylaxis to systemic but not to airways responses during prolonged therapy with high dose inhaled salbutamol in asthmatics. Am Rev Respir Dis 1989; 140: 586– 92. 29 Brodde OE, Brinkmann M, Schemoth R, O'Hara N, Daul A. Terbutaline induced desensitization of human lymphocyte beta-2 adrenoceptors. Accelerated restoration of beta-adrenoceptor responses by prednisolone and ketotifen. J Clin Invest 1985; 76: 1096– 101. 30 Brodde OE, Howe U, Egerszegi S, Konietzko N, Michel MC. Effect of prednisolone and ketotifen on β2-adrenoceptors in asthmatic patients receiving β2-bronchodilators. Eur J Clin Pharmacol 1988; 34: 145– 50. 31 Roden DM, Iansmith DHS. Effects of low potassium or magnesium concentrations on isolated cardiac muscle. Am J Med 1987; 82(Suppl. 3A): 18– 23. 32 Surawicz B, Lepeschkin E, Herrlich HC, Hoffman BF. Effect of potassium and calcium deficiency on the monophasic action potential, electrocardiogram and contractility of isolated rabbit hearts. Am J Physiol 1959; 196: 1302– 7. 33 Stewart DE, Ikram H, Espiner E, Nichols GM. Arrhythmogenic potential of diuretic induced hypokalaemia in patients with mild hypertension and ischaemic heart disease. Br Heart J 1985; 54: 290– 7. 34 Nordrehaug JE, Johannessen KE, Von Der Lippe, G. Serum potassium concentration as a risk factor of ventricular arrhythmias early in acute myocardial infarction. Circulation 1985; 71: 645– 9. 35 Lipworth BJ, Tregaskis BF, McDevitt DG. Comparison of hypokalaemic, electrocardiographic and haemodynamic responses to inhaled isoprenaline and salbutamol in young and elderly subjects. Eur J Clin Pharmacol 1991; 40: 255– 60. 36 Surawicz B, Knoebel S. Long QT: good, bad or indifferent? J Am Coll Cardiol 1985; 4: 494– 516. 37 McDevitt DG, Shanks RG, Swanton RG. Further observations on the cardiotoxicity of isoprenaline during hypoxia. Br J Pharmac 1974; 50: 335– 44. 38 Lipworth BJ, McDevitt DG, Struthers AD. Prior treatment with diuretic augments the hypokalaemic and electrocardiographic effects of inhaled albuterol. Am J Med 1989; 86: 653– 7. 39 Magnussen H, Rabe KF. Low dose fenoterol aerosol protects against histamine-induced bronchoconstriction in mild asthmatics: a dose-response study. Clin Exp Allergy 1992; 22: 689– 92. 40 Britton J, Hanley SP, Garnett HV, Hadfield JW, Tatters-field, AE. Dose related effects of salbutamol and ipratropium bromide on airway calibre and reactivity in subjects with asthma. Thorax 1988; 43: 300– 5. 41 Vathenen AS, Knox AJ, Higgins BG, Britton JR, Tatters-field AE. Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline. Lancet 1988; 1: 554– 8. 42 Hauck RW, Bohm M, Gengenbach S, Sunder-Plassmann L, Fruhmann G, Erdmann E. β2-adrenoceptors in human lung and peripheral mononuclear leukocytes of untreated and terbutaline treated patients. Chest 1990; 98: 376– 81. 43 Kerrebijn KF, van Essen-Zandvliet EEM, Neijens HJ. Effects of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma. J Allergy Clin Immunol 1987; 79: 653– 9. 44 Kraan J, Koeter GH, van der Mark TW, Sluiter HJ, de Vries K. Changes in bronchial hyperreactivity induced by 4 weeks treatment with anti-asthma drugs in patients with allergic asthma: a comparison of budesonide and terbutaline. J Allergy Clin Immunol 1985; 76: 628– 36. 45 van Schayck CP, Visch MB, van Herwaarden CLA, Dorpeling H, van Wed C. Increased bronchial hyperresponsiveness after inhaling salbutamol during one year is not caused by desensitisation to salbutamol. J Allergy Clin Immunol 1990; 86: 793– 800. 46 Paggiaro PL, Dente FL, Vagaggini B, Bacci E, Talini D, Testi R, Mapp CE, Babbri LM, Giuntini C. Salbutamol plus beclomethasone diproprionate, but not salbutamol alone, completely prevent early and late asthmatic responses to allergen. Respir Med 1991; 85: 401– 6. 47 Waalkens HJ, Gerristen J, Koeter GH, Krouvvels FH, van Aalderen WMC, Knol K. Budesonide and terbutaline or terbutaline alone in children with mild asthma: effects on bronchial hyperresponsiveness and diurinal variation in peak flow. Thorax 1991; 46: 499– 503. 48 van Schayck CP, Dompeling E, van Herwaarden CLA et al. Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand. A randomised controlled study. Br Med J 1991; 303: 1426– 31. 49 Ullman A, Svedmyr N. Salmeterol, a new long-acting inhaled β2-adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients. Thorax 1988; 43: 674– 8. 50 Maesen FPV, Smeets JJ, Gubbelmans, JLL, Zweers PGM. Formoterol in the treatment of nocturnal asthma. Chest 1990 98: 866– 76. 51 McAlpine LG, Thomson NC. Prophylaxis of exercise-induced asthma with inhaled formoterol, a long-acting β2-adrenergic agonist. Respir Med 1990; 84: 293– 5. 52 Ramsdale HE, Otis J, Kline PA, Gontovnick LS, Hargreave FE, O'Byrne PM. Prolonged protections against methacholine-induced bronchoconstriction by the inhaled β2-agonist formoterol. Am Rev Respir Dis 1991; 143: 998– 1001. 53 Lofdahl CG, Svedmyr N. Formoterol fumarate, a new β2-adrenoceptor agonist. Allergy 1989; 44: 264– 71. 54 Twentyman O, Finnerty JP, Harris A, Palmer J, Holgate ST. Protection against allergen-induced asthma by salmeterol. Lancet 1990; 336: 1338– 42. 55 Butchers PR, Cousins SA, Vardey CJ. Salmeterol: a potent and long acting inhibitor of the release of inflammatory and spasmogenic mediations from human lung. Br J Pharmac 1987; 92(Suppl): 745P. 56 O'Shaughnessy K, Taylor IK, Fuller RW. β2-agonists in asthma (letter). Lancet 1991; 337: 45– 6. 57 Ullman A, Hedner J, Svedmyr N. Inhaled salmeterol and salbutamol in asthmatic patients: an evaluation of asthma symptoms and the possible development of tachyphylaxis. Am Rev Respir Dis 1990; 142: 571– 5. 58 Arvidsson P, Larsson S, Lofdahl CG, Melander B, Wahlander L, Svedmyr N. Formoterol, a new long-acting bronchodilator for inhalation. Eur Respir J 1989; 2: 325– 30. Citing Literature Volume22, Issue7July 1992Pages 659-664 ReferencesRelatedInformation